Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance

Intrinsic clearance (CLint) of seven probe cytochrome P450 substrates, across a wide range of clearance, was compared in microsomes and cryopreserved hepatocytes from the same four livers. Previous comparisons have shown system dependence, but using preparations from different donor livers. Four-fold average underprediction of microsomal CLint by hepatocytes (scaled to whole liver) for high clearance substrates (midazolam, nifedipine, and diclofenac) was observed with relatively unbiased prediction (within 1.5-fold average) for the low/medium clearance substrates (tolbutamide, alprazolam, bufuralol, and triazolam). CLint of midazolam and nifedipine corresponded between livers over a tenfold range, but the absolute ranges were lower for hepatocytes, indicating independence of hepatocyte bias from substrate. In contrast, the absolute ranges of CLint for the low clearance CYP3A4 substrate alprazolam were similar between the systems, indicating independence of hepatocyte bias from enzyme. The trend in CLint between the systems was similar to that in a dataset of published CLint for 46 substrates in microsomes and hepatocytes (unrelated liver sources), supporting a fundamental rate limitation of the hepatocyte system. A tendency of decreasing Vmax in hepatocytes relative to microsomes, with increasing clearance, suggests that a capacity limitation, such as cofactor rate limitation, may be involved in this phenomenon.

[1]  J. Houston,et al.  Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective View , 2010, Pharmaceutical Research.

[2]  J B Houston,et al.  Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systems. , 2009, Current drug metabolism.

[3]  Aleksandra Galetin,et al.  Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes , 2009, Drug Metabolism and Disposition.

[4]  Michael Gertz,et al.  Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data , 2008, Drug Metabolism and Disposition.

[5]  J. Houston,et al.  Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  M Baker,et al.  Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  R. Riley,et al.  The pivotal role of hepatocytes in drug discovery. , 2007, Chemico-biological interactions.

[8]  Albert P. Li,et al.  Human hepatocytes: isolation, cryopreservation and applications in drug development. , 2007, Chemico-biological interactions.

[9]  J Brian Houston,et al.  Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance , 2007, Drug Metabolism and Disposition.

[10]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[11]  John C Lipscomb,et al.  Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. , 2007, Current drug metabolism.

[12]  Chuang Lu,et al.  Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes , 2006, Drug Metabolism and Disposition.

[13]  J Brian Houston,et al.  BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT , 2006, Drug Metabolism and Disposition.

[14]  R J Riley,et al.  The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions. , 2006, Current drug metabolism.

[15]  Kiyomi Ito,et al.  Determination of a Human Hepatic Microsomal Scaling Factor for Predicting in Vivo Drug Clearance , 2006, Pharmaceutical Research.

[16]  J B Houston,et al.  Microsomal prediction of in vivo clearance and associated interindividual variability of six benzodiazepines in humans , 2005, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  Lewis B. Sheiner,et al.  Some suggestions for measuring predictive performance , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[18]  Hannah M Jones,et al.  SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS , 2004, Drug Metabolism and Disposition.

[19]  Kiyomi Ito,et al.  Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes , 2004, Pharmaceutical Research.

[20]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[21]  R. Obach,et al.  Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[22]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[23]  S. Wrighton,et al.  Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  R. Obach,et al.  Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. , 1997, Drug metabolism and disposition: the biological fate of chemicals.